Prestige Wealth Management Group’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-9
Closed -$1K – 1062
2021
Q3
$1K Buy
+9
New +$1.31K ﹤0.01% 939
2021
Q2
– Sell
-19
Closed -$4K – 1032
2021
Q1
$4K Buy
19
+14
+280% +$3.25K ﹤0.01% 684
2020
Q4
$1K Buy
+5
New +$1.02K ﹤0.01% 893
2020
Q2
– Sell
-341
Closed -$53K – 956
2020
Q1
$53K Buy
+341
New +$39.7K 0.02% 177

Other funds holding TDOC

Prestige Wealth Management Group's TDOC Position: Q4 2021 in Review

Prestige Wealth Management Group sold out of Teladoc Health (TDOC) in Q4 2021, closing a stake of 9 shares — an estimated $1K sold.

Prestige Wealth Management Group first reported a position in TDOC in Q1 2020 and held it in 4 quarters. The position peaked at $53K in Q1 2020. 729 funds tracked by Wall St. Rank hold TDOC as of Q4 2021.

  • Prestige Wealth Management Group reported no remaining Teladoc Health position as of Q4 2021 after selling out during the quarter.
  • Prestige Wealth Management Group sold 9 Teladoc Health shares in Q4 2021, an estimated $1K.
  • Prestige Wealth Management Group first reported a position in Teladoc Health in Q1 2020 and held it in 4 quarters.
  • Prestige Wealth Management Group's Teladoc Health position peaked at $53K in Q1 2020.
  • 729 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2021.

Based on Prestige Wealth Management Group's 13F filing for Q4 2021, filed 15 Feb 2022.